2015 ICD-9-CM Diagnosis Code 209.22
Malignant carcinoid tumor of the thymus
- 2015
- Billable Thru Sept 30/2015
- Non-Billable On/After Oct 1/2015
- ICD-9-CM 209.22 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 209.22 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM:
209.22 converts directly to:
- 2015/16 ICD-10-CM C7A.091 Malignant carcinoid tumor of the thymus
Approximate Synonyms
- Cancer of the thymus, carcinoid tumor
- Malignant carcinoid tumor of thymus
- Malignant carcinoid tumor, thymus
- Malignant neuroendocrine tumor of thymus
- Malignant neuroendocrine tumor, thymus
- Primary malignant neuroendocrine tumor of thymus
Clinical Information
- A primary thymic neuroendocrine neoplasm, often associated with cushing's syndrome. Two morphologic subtypes are recognized: typical and atypical carcinoid tumors. Atypical carcinoid tumors have a more aggressive clinical course
- A primary thymic neuroendocrine tumor, often associated with cushing syndrome. Two morphologic subtypes are recognized: typical and atypical carcinoid tumors. Atypical carcinoid tumors have a more aggressive clinical course
carcinoid (M8240/1) 209.60
benign 209.60
